Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
出版年份 2015 全文链接
标题
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
作者
关键词
Breast cancer, Aromatase inhibitors, Endocrine resistance, Estrogen receptor, Biomarkers, TFF3
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 154, Issue 3, Pages 483-494
出版商
Springer Nature
发表日期
2015-11-19
DOI
10.1007/s10549-015-3644-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells
- (2015) Stine Hole et al. BREAST CANCER RESEARCH AND TREATMENT
- Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma
- (2015) Angela E. Zou et al. RNA
- Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma
- (2015) Nagarajan Kannan et al. NEOPLASIA
- Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
- (2014) M. Arnedos et al. ANNALS OF ONCOLOGY
- Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia
- (2013) Domenica Ronchetti et al. BMC Medical Genomics
- GDNF-RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors
- (2013) A. Morandi et al. CANCER RESEARCH
- Molecular Profiling of Aromatase Inhibitor-Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
- (2013) A. K. Dunbier et al. CLINICAL CANCER RESEARCH
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
- (2013) Ivana Sestak et al. JNCI-Journal of the National Cancer Institute
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- TFF3 Is a Normal Breast Epithelial Protein and Is Associated with Differentiated Phenotype in Early Breast Cancer but Predisposes to Invasion and Metastasis in Advanced Disease
- (2012) Ahmed R.H. Ahmed et al. AMERICAN JOURNAL OF PATHOLOGY
- Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer
- (2012) M. T. Weigel et al. ANNALS OF ONCOLOGY
- Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
- (2011) G. Viale et al. ANNALS OF ONCOLOGY
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
- (2011) Meredith M Regan et al. LANCET ONCOLOGY
- Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
- (2010) Xiaohong R. Yang et al. JNCI-Journal of the National Cancer Institute
- Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole
- (2009) William R. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now